ClinicalTrials.gg
Sign In

Neuroectodermal Tumors, Primitive, Peripheral clinical trials

The registry lists 135 studies for Neuroectodermal Tumors, Primitive, Peripheral across more than 10 countries. 2 are recruiting or about to start. 14 of them are mainly about Neuroectodermal Tumors, Primitive, Peripheral (how this is decided). Per ClinicalTrials.gov, last updated 2026-11-04. Counting its 3 narrower conditions too, such as Neuroblastoma: 821 studies, 132 open.

Get an email when these change. Save the Neuroectodermal Tumors, Primitive, Peripheral studies recruiting or about to start — once a week, free: studies that open, close, add sites or post results.

Watch these studies
See an example email

Example · made-up studies

Breast cancer · Recruiting: 2 came in, 3 changed

What changed in your saved searches, Oct 31 – Nov 6:

A study of drug A after surgery for early breast cancer

Came in · now Recruiting

Drug B with hormone therapy in advanced breast cancer

Changed

· Sites: 4 added, including Seoul and Busan

· Enrollment: 300 → 450 participants

Exercise during chemotherapy

Now Active, not recruiting

One email a week for all your saved searches. Stop any time.

Status

Completed
98
Terminated
13
Active, not recruiting
10
Status unknown
7
Withdrawn
5
Recruiting
2

Phase

Phase 2
68
Phase 1
44
Phase 3
9
Early Phase 1
2

Where

United States
112
Puerto Rico
24
Canada
23
Australia
19
United Kingdom
8
New Zealand
7

Who runs them

National Cancer Institute (NCI) (37) · Children's Oncology Group (22) · Memorial Sloan Kettering Cancer Center (9) · City of Hope Medical Center (7) · National Institutes of Health Clinical Center (CC) (5) · Institut Curie (3) · Dana-Farber Cancer Institute (3) · Milton S. Hershey Medical Center (3)

What is being tested here

Drugs under test in Neuroectodermal Tumors, Primitive, Peripheral studies, those with the most open studies first. Medicines only given beside them are not counted. How drugs are counted

DrugOpenPhase 3All
Temozolomide117
Talazoparib102
177Lu-octreotide, DOTA(0)-Tyr(3)-101
Etoposide0112
Melphalan0111
Cyclophosphamide0110
Ifosfamide0110
Busulfan018
Doxorubicin017
Carboplatin007

Drug classes tested here Alkylating agents 1 open · PARP inhibitors 1 open · Antimitotic agents 14 · Tyrosine kinase inhibitors (TKIs) 13 · Antimetabolites 5

Coming up

0phase 3 studies under way
3studies finish main data collection within a year

Studies recruiting or running, from their records. “Main data collection” ends at the primary completion date, the sponsor’s own estimate, which often moves.

All 3

Who these studies take

Of the 2 Neuroectodermal Tumors, Primitive, Peripheral studies recruiting now, 0 (0%) set no upper age limit and 2 (100%) stop at 75 or younger. 2 (100%) take children under 18. 0 (0%) are for women only and 0 (0%) for men only; 0 (0%) take healthy volunteers.

Recruiting studies that take each age, of 2
AgeWomenMen
102 (100%)2 (100%)
182 (100%)2 (100%)
301 (50%)1 (50%)
400 (0%)0 (0%)
500 (0%)0 (0%)
650 (0%)0 (0%)
750 (0%)0 (0%)
850 (0%)0 (0%)

Across all 135 studies, recruiting or not: 73% stop at 75 or younger and 71% at 65; 87% take children; 0% are for women only and 0% for men only; 1% take healthy volunteers. From each study’s registry entry; the criteria on its page decide.

How long Neuroectodermal Tumors, Primitive, Peripheral studies take

Of 20 phase 2 interventional studies under Neuroectodermal Tumors, Primitive, Peripheral, half reached primary completion within 56 months of starting, counting those still running.

Start to primary completionEvery sponsorIndustryNon-industry
Phase 256 mo41–70 · 20 studies—56 mo41–70 · 20 studies

Each figure is the month by which half the studies had reached primary completion, with the range in which the middle half did. Studies still running count until their last registry update; studies that stopped early are left out. Phase 1 includes early phase 1; observational means prospective or not stated, as retrospective and cross-sectional studies date a window of data rather than a study. How these figures are worked out

Studies

Recruiting first, then most recently updated. Showing 50 of 135. Browse all 135 → or search them.